Aescap Life Sciences Newsletter Q2 2022

Solid performance across portfolio. Due to a strong net performance of +13,2% since we published our NAV of mid June, the net performance of the fund for June ended at +8,8%.

Aescap Life Sciences Newsletter Q2 2022